# MedShield Thesis Adviser Progress Report and SMART Checklist

**Reporting date:** September 4, 2026  
**Project:** MedShield Enterprise Decision-Support System (DSS)  
**Reporting scope:** Analytical models, data pipeline, system integration, and verification  
**Status language:** `Verified` means supported by a repository artifact or a check run on September 4, 2026. `Prototype` means implemented but not approved for operational use. `Planned` means not yet complete.  
**Planning note:** The target dates below are proposed dates and should be aligned with the actual adviser schedule.

## 1. Executive Progress Statement

MedShield has progressed beyond a user-interface prototype. The repository now contains a governed multi-year data pipeline, reproducible analytical jobs, model evaluation outputs, protected backend integration, dashboard components, database migrations, and automated tests.

The strongest verified accomplishment is the Databricks Bronze–Silver–Gold workflow for nine annual sales files covering 2017–2025. The Gold candidate layer contains 40,086 analysis-ready transactions and reconciles to a protected nine-row yearly candidate extract with a recorded checksum. Descriptive models for ABC/Pareto, seasonality, year-over-year analysis, product performance, and territory performance have also produced reproducible output files.

Predictive and prescriptive models exist as working prototypes, but they are not yet final operational recommendations. Current forecast errors are high, external disease/weather coverage has limitations, and inventory policy inputs are incomplete. The academically defensible position is therefore: **the analytical workflow and system integration are demonstrably implemented, while model validation, approval, and final dashboard publication remain in progress.**

## 2. Progress Dashboard

| Workstream | Current status | Verified result | Adviser-safe interpretation |
|---|---|---|---|
| Multi-year data pipeline | Verified | Nine annual files; 2017–2025; 40,086 Gold fact rows | A governed and traceable analytical dataset has been produced. |
| Data quality | Verified, with review queues | 4,633 quarantined rows; 234 duplicate-review rows; 18 governed quality rules | Invalid or uncertain records are retained for review rather than silently discarded. |
| Gold data model | Verified | 3,287 dates, 20 areas, 4,900 products, 7,893 product-year rows | The warehouse supports time, territory, product, and quality analysis. |
| Gold analytical marts | Verified as candidates | 108 monthly, 9 yearly, 180 area-year, and 7,893 product-year rows | Dashboard-ready aggregates exist but publication approval is still controlled. |
| Descriptive analytics | Verified draft | ABC/Pareto, seasonality, year-over-year, product, territory, and monthly outputs | The system can explain what happened in historical sales. |
| Predictive analytics | Prototype evaluated | Seasonal-naive, Prophet, GBR/Ridge disease, weather, XGBoost, and classical-model experiments have evaluation artifacts | Models run, but current error rates do not justify calling the forecasts accurate or production-ready. |
| Prescriptive analytics | Scenario prototype | EOQ, ROP, safety stock, MCDA, allocation, matching, and rule-based logic exist | These demonstrate decision logic; real recommendations require approved inventory and policy inputs. |
| Databricks-to-application integration | Partly verified | Gold connection and protected yearly candidate synchronization are implemented; yearly extract contains 9 rows and 40,086 reconciled transactions | Backend integration works for the yearly candidate scope; full dashboard cutover is unfinished. |
| Dashboard/system | Implemented, not fully cut over | Next.js frontend, TypeScript gateway, Python analytics service, Supabase migrations, and model dashboard components exist | The system is demonstrable, but normal dashboard use can still rely on the bundled fallback dataset. |
| Automated verification | Verified September 4, 2026 | 19 service tests pass; 10 Databricks tests pass; backend and frontend production builds pass | Core data rules and application compilation are currently reproducible. |

## 3. Evidence and Proof Checklist

### A. Data engineering and governance

- [x] Show the documented Bronze–Silver–Gold architecture and explain the purpose of each layer.  
  **Proof:** `docs/MEDSHIELD_PROJECT_PROGRESS_TRACKER.md`, `databricks/docs/DATABRICKS_DATA_CLEANING_WORKFLOW.md`, and `databricks/src/medshield_etl/`.
- [x] Show that the source period covers 2017–2025.  
  **Proof:** `outputs/databricks/gold_yearly_sales_candidate.json` records a minimum year of 2017, maximum year of 2025, and nine years.
- [x] Show the analysis-ready Gold population.  
  **Proof:** the same Gold extract records `source_transaction_count: 40086` and the source view `workspace.medshield_gold.vw_dashboard_yearly_sales_candidate`.
- [x] Explain how questionable records are handled.  
  **Proof:** the progress tracker records 4,633 quarantine rows, 234 duplicate-review rows, and the governed quality-rule counts.
- [x] Show reconciliation rather than only row cleaning.  
  **Proof:** `outputs/contract_backward_allocation_20260623/reconciliation.json` records zero deltas for quantity and all listed financial measures after backward allocation.
- [ ] Capture a readable Databricks screenshot showing the latest successful job/run and Gold view counts.
- [ ] Export the latest Gold validation query results as a dated evidence file or screenshot.

### B. Descriptive analytical models

- [x] Present ABC/Pareto as the product and territory contribution method.  
  **Proof:** `outputs/descriptive_analytics_20260825/descriptive_product_abc_pareto.csv` and `descriptive_territory_abc_pareto.csv`.
- [x] Present seasonality and year-over-year analysis as descriptive evidence.  
  **Proof:** `descriptive_seasonality_overall.csv`, `descriptive_seasonality_territory.csv`, `descriptive_yoy_overall.csv`, and `descriptive_yoy_territory.csv` in the same output folder.
- [x] Present the run summary and limitations.  
  **Proof:** `outputs/descriptive_analytics_20260825/descriptive_run_summary.json` records 37,340 rows, 2017-01-02 to 2025-12-31 coverage, draft status, and identified data-quality limitations.
- [ ] Reconcile the descriptive output against the current 40,086-row Gold population or document why the older descriptive run used 37,340 rows.
- [ ] Obtain final approval for product aliases, medical/non-medical classification, territory mapping, and financial definitions before labeling results final.

### C. Predictive analytical models

- [x] Show that baseline and challenger models have been executed and measured.  
  **Proof:** `outputs/model_evaluation_report.md`, `outputs/phase4_disease_model_results.json`, and `outputs/phase5_weather_model_results.json`.
- [x] Report MAE, RMSE, and MAPE rather than showing forecasts without accuracy evidence.
- [x] Disclose that the disease and weather challengers do not yet establish a reliable operational forecast. The recorded MAPE values are very high, and disease correlations in the Phase 4 artifact are weak (absolute values below 0.09).
- [x] Disclose that the Phase 5 rainfall and temperature correlations are recorded as `NaN`, the 2025 holdout is partial, and weather data is a proxy rather than official station-level PAGASA data.
- [ ] Define a publication gate before model tuning: agreed holdout period, zero-demand-safe metrics such as WAPE/sMAPE, benchmark comparison, and an adviser-approved error threshold.
- [ ] Retrain and compare candidates using the reconciled Gold dataset and approved medical-product scope.
- [ ] Publish a model card containing data version, features, train/test periods, metrics, limitations, and decision-use label.

### D. Prescriptive analytical models

- [x] Demonstrate implemented scenario logic for EOQ, ROP, safety stock, MCDA, allocation, recommendation matching, and alerts.  
  **Proof:** `services/analytics_service/medshield_engine.py`, `services/analytics_service/commercial_mcda.py`, `outputs/eoq_from_real_sales.json`, and model-dashboard components under `frontend/components/dashboard/model-dashboard/`.
- [x] Label all outputs as scenario-based decision support, not automatic procurement instructions.
- [ ] Collect and approve current inventory, supplier lead time, ordering cost, holding cost, service-level, budget, and storage-capacity inputs.
- [ ] Recompute EOQ/ROP/safety-stock results using approved inputs and validate at least three representative SKUs with a domain owner.
- [ ] Validate MCDA criteria and weights with the project owner/adviser and record the approval.

### E. Application and integration

- [x] Show the TypeScript gateway, Python analytics service, Next.js frontend, Supabase migrations, and Databricks workflow as separate system layers.
- [x] Show protected backend-only Databricks connection and synchronization logic.  
  **Proof:** `backend/src/databricks.ts`, `backend/src/databricksYearlySync.ts`, and `supabase/migrations/013_databricks_yearly_candidate_sync.sql` through `015_approved_financial_semantics.sql`.
- [x] Show the extracted yearly Gold candidate.  
  **Proof:** `outputs/databricks/gold_yearly_sales_candidate.csv` and `.json`, checked September 3, 2026.
- [ ] Extend protected synchronization to monthly, area-year, product-year, quality, exclusion, and transaction-level Gold outputs.
- [ ] Reconcile every dashboard KPI to the Gold source.
- [ ] Disable the bundled demonstration fallback only after reconciliation and rollback evidence are complete.
- [ ] Capture final screenshots of login, overview, sales ledger, filters, model/evaluation view, data quality, and administrative integration controls.

### F. Quality assurance and reproducibility

- [x] Service/data tests passed on September 4, 2026: **19 of 19**.
- [x] Databricks configuration/contract tests passed on September 4, 2026: **10 of 10**, using the `databricks/src` package path.
- [x] Backend TypeScript production build passed on September 4, 2026.
- [x] Frontend Next.js production build passed on September 4, 2026; five static pages were generated.
- [ ] Run the Playwright end-to-end suite against a controlled local environment and save the HTML report or screenshots.
- [ ] Repeat authenticated API smoke tests against the current integrated dataset; do not reuse exposed tokens or include secrets in evidence.
- [ ] Create a dated evidence index containing commands, timestamps, screenshots, output hashes, and responsible group member.

## 4. Current Verification Record — September 4, 2026

| Check | Command | Result |
|---|---|---|
| Service and data unit tests | `python -m unittest discover -s services\tests -p "test_*.py" -v` | Pass: 19 tests |
| Databricks contracts/configuration | From `databricks/`, set `PYTHONPATH` to `src`, then run `python -m unittest discover -s tests -p "test_*.py" -v` | Pass: 10 tests |
| Backend production build | From `backend/`, run `npm run build` | Pass |
| Frontend production build | From `frontend/`, run `npm run build` | Pass; routes `/`, `/_not-found`, and `/login` built |

An older integrated QA artifact, `outputs/system_qa_report.json`, records 57 of 57 API/UI smoke checks passing on August 9, 2026. Present this as historical evidence, not as a substitute for a new end-to-end run.

## 5. SMART Objectives for the Next Two Weeks

| ID | SMART objective | Measure of completion | Target date | Owner role | Evidence to produce |
|---|---|---|---|---|---|
| S1 | Reconcile the latest descriptive analytics to the 40,086-row Gold population and document all exclusions. | One signed reconciliation table where source, excluded, and published counts balance; zero unexplained row-count differences. | September 7, 2026 | Data Analyst | Dated CSV/JSON reconciliation plus one-page interpretation |
| S2 | Approve the analytical business definitions and master-data scope used for publication. | Written approval for revenue, acquisition cost, gross margin, medical-product classification, product aliases, and territory mapping; every unresolved item logged. | September 8, 2026 | Business Analyst / Project Owner | Completed approval checklist and decision record |
| S3 | Publish the 108-row monthly Gold candidate through the protected Supabase/backend pattern. | Exactly 108 monthly rows covering 2017-01 through 2025-12; source and target counts/checksums match; rerun proves idempotency. | September 10, 2026 | Data / Backend Engineer | Pipeline log, SQL result, checksum, and screenshot |
| S4 | Establish and execute the predictive-model validation protocol on the approved Gold/medical dataset. | One fixed holdout; seasonal-naive benchmark plus at least two challengers; MAE, RMSE, WAPE, sMAPE, and bias reported; publication decision recorded. | September 14, 2026 | Analytics Lead | Reproducible run, metrics table, residual plot, model card |
| S5 | Validate prescriptive scenarios using approved operational assumptions. | Approved inputs for at least three representative SKUs; EOQ, ROP, and safety-stock calculations independently recomputed with zero formula discrepancy. If inputs remain unavailable, mark the objective blocked and retain scenario labels. | September 15, 2026 | Business / Data Analyst | Assumption register and calculation-validation sheet |
| S6 | Complete dashboard-to-Gold reconciliation for the adviser demonstration scope. | Overview, yearly/monthly trend, product, area, data-quality, and model-evaluation values match their Gold/API sources; no unexplained differences. | September 17, 2026 | Frontend / Backend / QA | KPI traceability matrix and screenshots |
| S7 | Run a release-candidate evidence suite and prepare the adviser demonstration pack. | 19 service tests and 10 Databricks tests still pass; both production builds pass; critical Playwright journey passes; no unresolved critical defect; at least eight labeled screenshots captured. | September 18, 2026 | QA / Technical Writer | Test log, defect register, screenshot index, and five-minute demo script |

## 6. Definition of Done for the Adviser Demonstration

The adviser progress package is ready when all of the following are true:

- [ ] Every statement in the presentation has a linked file, screenshot, test result, or reproducible command.
- [ ] Implemented, validated, candidate, scenario, and planned outputs are visually distinguished.
- [ ] The team can explain the complete path from source file to dashboard decision.
- [ ] The 40,086-row Gold population and the displayed dashboard totals reconcile for the demonstrated scope.
- [ ] Forecast results include benchmark comparison and error metrics; high error is discussed honestly.
- [ ] Prescriptive results disclose their assumptions and do not claim automatic procurement.
- [ ] No credentials, service-role keys, bearer tokens, or sensitive `.env` values appear in screenshots.
- [ ] The demonstration can be repeated from a documented setup without relying on an unexplained manual step.
- [ ] A rollback/fallback plan is documented before the bundled demo data is disabled.

## 7. Five-Minute Adviser Reporting Script

1. **Problem and value — 30 seconds:** “MedShield is a decision-support system for analyzing historical pharmaceutical distribution demand and supporting product, territory, and inventory-planning review.”
2. **Data progress — 60 seconds:** “We implemented a Bronze–Silver–Gold pipeline across nine files from 2017–2025. The Gold candidate contains 40,086 analysis-ready transactions. Questionable rows remain traceable in quarantine and review queues.”
3. **Analytical progress — 90 seconds:** “Our reproducible descriptive layer now produces ABC/Pareto, seasonality, year-over-year, product, and territory outputs. We have also executed predictive benchmarks and disease/weather challengers. The models run, but current errors are high, so we are treating them as evaluated prototypes while we improve the dataset and validation protocol.”
4. **Decision-support progress — 45 seconds:** “EOQ, reorder point, safety stock, MCDA, allocation, matching, and alert logic are implemented as scenarios. We will not claim operational recommendations until inventory and policy assumptions are approved.”
5. **System proof — 45 seconds:** “The Next.js frontend, TypeScript API gateway, Python analytics service, Supabase serving layer, and Databricks Gold integration are implemented. Protected yearly synchronization has produced nine annual rows representing 40,086 transactions.”
6. **Quality proof and next commitment — 30 seconds:** “As of September 4, 19 service tests and 10 Databricks tests pass, and both production builds pass. Our next SMART milestone is full KPI reconciliation, model-card validation, and a dated evidence pack by September 18.”

## 8. Risks and Honest Limitations to State

- Forecast accuracy is currently insufficient for an “accurate prediction” claim. The correct claim is that several predictive models have been implemented and evaluated.
- The external-regressor evidence is limited: disease data is not territory-level in the cited model artifact, weather uses proxy data, some weather correlations are undefined, and the holdout period is partial.
- Product, territory, and financial definitions require controlled approval; older output folders may use different row populations and should not be mixed without reconciliation.
- Some historical documentation contains stronger interpretations than the recorded metrics support. The presentation should use this report’s conservative wording and the raw evidence artifacts.
- EOQ, ROP, safety-stock, MCDA, and allocation values are scenarios until real inventory and policy inputs are approved.
- The full dashboard has not yet been cut over to all Gold outputs; the bundled fallback should remain enabled until reconciliation and rollback checks are complete.
- The repository currently contains uncommitted changes, including a Databricks extraction script, backend package modification, output files, and source-data filename replacements. Treat those artifacts as working evidence until reviewed and committed.

## 9. Questions to Ask the Adviser

1. Is it acceptable to present predictive modeling as an evaluated prototype if the benchmark errors remain high, provided the limitations and improvement plan are explicit?
2. Which primary accuracy metric should govern publication for sparse or zero-demand monthly data: WAPE, sMAPE, MAE, or a combination?
3. Should the final thesis prioritize a reliable sales-only baseline over a disease/weather-adjusted model that does not yet improve the benchmark consistently?
4. Is scenario-based prescriptive analytics acceptable when inventory-policy inputs are unavailable, or must the team collect a minimum operational dataset before defense?
5. What evidence format does the adviser prefer for Chapter 4: screenshots, output tables, repository links, or an appendix containing all three?

